Use of cannabidiol in the treatment of drug-refractory epilepsy in children and young adults: A systematic review.
Samuel Fernando Vargas ChicoDaniel Alejandro Melendez DiazNeyder ContrerasPublished in: Journal of neurosciences in rural practice (2024)
The CBD emerges as a promising tool for refractory epilepsy in pediatric patients, showing efficacy in reducing seizure frequency and improving overall quality of life. Despite mild and reversible adverse effects, CBD's benefits outweigh the risks. However, more research on long-term effects is needed to fully understand its implications.